Financials
| Interim Results and feasibility study update | Sep. 30, 2025 |
| 2024 Annual Report and Consolidated Financial Statements | Apr. 30, 2025 |
| 2024 Final Results | Apr. 30, 2025 |
| Interim Results | Sep. 26, 2024 |
| Final Results | Apr. 29, 2024 |
| Half-year Report | Sep. 11, 2023 |
| Trading Update | Aug. 21, 2023 |
Proxies
| Result of 2025 AGM | Nov. 14, 2025 |
| Notice of AGM | Oct. 09, 2025 |
| Result of 2024 AGM | Oct. 23, 2024 |
| Notice of AGM | Sep. 19, 2024 |
| Result of AGM | Nov. 01, 2023 |
| Result of AGM | Nov. 10, 2022 |
| Notice of AGM | Oct. 13, 2022 |
Ownership Update
| Grant of Share Options | May. 02, 2025 |
| Holding(s) in Company | Nov. 22, 2023 |
| Director/PDMR Shareholding | Nov. 21, 2023 |
| Directors Share Purchase | May. 02, 2023 |
| Holding(s) in Company | Sep. 27, 2022 |
| Grant of Options | Sep. 22, 2022 |
| Grant of Options | Jun. 29, 2022 |
Announcements
| Issue of Equity | Dec. 05, 2025 |
| Positive Feasibility Study Results | Oct. 13, 2025 |
| Issue of Equity | Jul. 07, 2025 |
| CBS Product Update and Feasibility Study Update | Jun. 27, 2025 |
| Appointment of Lead Financial Adviser | Jun. 23, 2025 |
| Framework Agreement for Phase 1 of Balasausqandiq | Jun. 02, 2025 |
| Issue of Equity to Supplier | Mar. 06, 2025 |
Prospectuses
| Issue of Bonds | Jan. 11, 2021 |
| Issue of Bonds | Nov. 11, 2020 |